S. Costarelli

M. Prosperi, S. Di Giambenedetto, C. Torti, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Screening and Management of HIV-2-Infected Individuals in Northern Italy.

F. Baldanti, C. Torti, I. Izzo, 2008, AIDS patient care and STDs.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients.

C. Tinelli, P. Arosio, C. Torti, 2007, Journal of Acquired Immune Deficiency Syndromes.

Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients

L. Chatenoud, F. Castelli, A. Gori, 2015, Journal of acquired immune deficiency syndromes.

Influence of Folate Serum Concentration on Plasma Homocysteine Levels in HIV-Positive Patients Exposed to Protease Inhibitors Undergoing HAART

C. Torti, G. Carosi, F. Moretti, 2006, Annals of Nutrition and Metabolism.

Hepatitis C virus antibody‐positive patients with HIV infection have a high risk of insulin resistance: a cross‐sectional study

G. Guaraldi, C. Torti, G. Lapadula, 2008, HIV medicine.

Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment

M. Valsecchi, A. Gori, C. Torti, 2016, PloS one.

T20QoL: an observational multicenter cohort study to evaluate the quality of life in HIV-patients treated with enfuvirtide (ENF, T-20) in combination with an optimized background therapy

P. Narciso, A. Corpolongo, V. Tozzi, 2008, Biologics : targets & therapy.

Prevalence and Risk Factors for Etravirine Resistance among Patients Failing on Non-Nucleoside Reverse Transcriptase Inhibitors

C. Torti, N. Manca, G. Carosi, 2008, Antiviral therapy.

Short communication Prevalence and risk factors for etravirine resistance among patients failing on non-nucleoside reverse transcriptase inhibitors

C. Torti, N. Manca, G. Carosi, 2008 .

Switch from enfuvirtide (ENF) to raltegravir (RAL): a simplification option for heavily pretreated HIV patients (pts)

G. Carosi, P. Nasta, F. Gatti, 2008 .

Kidney transplantation in HIV-positive patients: a report of 14 cases

S. Sandrini, G. Setti, N. Bossini, 2012, Journal of the International AIDS Society.

Catheter-Associated Urinary Tract Infections (CAUTI): Distribution of Uropathogens and Patterns of Antimicrobial Resistance in an Italian Hospital (1996-2003)

G. Morelli, G. Pichierri, S. Costarelli, 2005, Journal of chemotherapy.

Plasma HIV load and proviral DNA decreases after two standard antiretroviral regimens in HIV-positive patients naïve to antiretrovirals.

M. Magoni, M. Nichelatti, A. Cossarizza, 2008, Current HIV research.

Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort.

S. Giambenedetto, S. Costarelli, S. Lorenzotti, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.